127 citations
,
May 2004 in “PubMed” Finasteride may help some male chronic pelvic pain patients, but more research needed.
105 citations
,
January 2004 in “The Journal of Urology” Finasteride improves chronic pelvic pain, saw palmetto doesn't.
1707 citations
,
December 2003 in “The New England Journal of Medicine” Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.
35 citations
,
May 2002 in “Journal of the European Academy of Dermatology and Venereology” Chronic prostatitis/pelvic pain syndrome (CPPS) was a common condition characterized by genital or pelvic pain lasting more than 3 months, with a prevalence of 2.5–3%. Unlike chronic bacterial prostatitis, CPPS did not involve infection, and its etiology was unclear, though neuromuscular origins and proinflammatory cytokines were implicated. The traditional four-glass test for distinguishing CPPS types lacked validation and clinical significance. While quinolone antibiotics were effective for chronic bacterial prostatitis, CPPS management was challenging due to the absence of reliable treatments. Commonly attempted treatments included antibiotics, anti-inflammatory agents, and alpha blockers, with newer trials exploring finasteride, quercetin, and rofecoxib. However, a systematic review indicated that existing diagnostic and treatment methods for CPPS lacked a robust evidence base.
65 citations
,
March 1999 in “Urology” Finasteride didn't significantly improve ICPPS symptoms, more research needed.
34 citations
,
January 1998 in “European Urology” Finasteride works best in 6 months and lasts 6 years.